Skip to main content
NCBI home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2002 Nov 14;60(1):39–62. doi: 10.1016/0163-7258(93)90021-5

Human natural interferon-α producing cells

Patricia Fitzgerald-Bocarsly 1
PMCID: PMC7133642  PMID: 8127923

Abstract

Interferons (IFNs) are critical components of the host immune system, serving as antiviral agents, immunomodulators and inhibitors of cell growth. Among peripheral blood mononuclear cells, the primary IFN-α-producing cell is a light density, HLA-DR+ cell negative for cell surface markers typical for T cells, B cells, monocytes, natural-killer or progenitor cells and has been tentatively the ‘natural’ IFN-producing cell' or NIPC. Although present in very low frequency (approximately 1:1000 among peripheral blood mononuclear cells), the NIPC are very potent, with an individual cell able to produce 1–2 IU of IFN. In this review, the characteristics, phenotype, regulation and relationship of NIPC to human disease are discussed.

Abbreviations: AC, accessory cell; AIDS, acquired immune deficiency syndrome; CMV, cytomegalovirus; gD, glycoprotein D; HIV, human immunodeficiency virus; HSV, herpes simplex virus; IFN, interferon; MHC, major histocompatibility complex; NIPC, natural interferon-producing cell; NK, natural killer; PBMC, peripheral blood mononuclear cells; PMA, phorbol myristate acetate; TGEV, transmissible gastroenteritis virus

References

  1. Abb J., Deinhardt F. Human IFN-alpha in homosexual men and the acquired immune deficiency syndrome. J. Infect. Dis. 1984;150:158. doi: 10.1093/infdis/150.1.158. [DOI] [PubMed] [Google Scholar]
  2. Abb J., Abb H., Deinhardt F. Phenotype of human α-interferon producing leucocytes identified by monoclonal antibodies. Clin. exp. Immun. 1983;52:179–184. [PMC free article] [PubMed] [Google Scholar]
  3. Abb J., Zachoval R., Eisenburg J., Paper G.R., Zachoval V., Deinhardt F. Production of interferon alpha and interferon gamma by peripheral blood leukocytes from patients with chronic hepatitis B virus infection. J. Med. Virol. 1985;16:171–176. doi: 10.1002/jmv.1890160209. [DOI] [PubMed] [Google Scholar]
  4. Aguet M., Dembic Z., Merlin G. Molecular cloning and expression of the human interferon-γ receptor. Cell. 1988;55:273–280. doi: 10.1016/0092-8674(88)90050-5. [DOI] [PubMed] [Google Scholar]
  5. Arvin A., Miller J. Acid labile α-interferon in sera and synovial fluids from patients with juvenile arthritis. Arthritis Rheum. 1984;17:582–585. doi: 10.1002/art.1780270517. [DOI] [PubMed] [Google Scholar]
  6. Bandyopadhyay S., Perussia B., Trinchieri G., Miller D.S., Starr S. Requirement for HLA-DR+ accessory cells in natural killing of cytomegalovirus-infected fibroblasts. J. exp. Med. 1986;164:180–195. doi: 10.1084/jem.164.1.180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bandyopadhyay S., Ziegner U., Campbell D.E., Miller D.S., Hoxie J.A., Starr S.E. Natural killer cell-mediated lysis of T cell chronically infected with HIV-1. Clin. exp. Immun. 1990;79:430–435. doi: 10.1111/j.1365-2249.1990.tb08107.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bernard A., Gay-Bellile V., Amiot M., Caillou B., Charbord P., Boumsell L. A novel human leukocyte differentiation antigen: monoclonal antibody anti-D44 defines a 28 Kd molecule present on immature hematologic cells and a subpopulation of mature T-cells. J. Immun. 1984;132:2338. [PubMed] [Google Scholar]
  9. Bishop G.A., Glorioso J.C., Schwartz S.A. Role of interferon in human natural killer activity against target cells infected with HSV-1. J. Immun. 1983;131:1849–1853. [PubMed] [Google Scholar]
  10. Buimovici-Klein E., Lange M., Klein J., Grieco M., Cooper L. Long-term follow-up of serum-interferon and its acid-stability in a group of homosexual men. AIDS Res. 1986;2:99–108. doi: 10.1089/aid.1.1986.2.99. [DOI] [PubMed] [Google Scholar]
  11. Cantell K., Hirvonen S., Kauppinen H.-L., Myllyla G. Production of interferon in human leukocytes from normal donors with the use of Sendai virus. Meth. Enzym. 1981;78:29–38. doi: 10.1016/0076-6879(81)78094-7. [DOI] [PubMed] [Google Scholar]
  12. Capobianchi M., DeMarco F., DiMarco P., Dianzani F. Acid-labile human interferon alpha production by peripheral blood mononucleadr cells stimulated by HIV-infected cells. Arch. Virol. 1988:9–19. doi: 10.1007/BF01311019. [DOI] [PubMed] [Google Scholar]
  13. Capobianchi M.R., Malavasi F., DiMarco P., Dianzani F. Differences in the mechanism of induction of interferon-alpha by herpes simplex virus-infected cells. Arch. Virol. 1988;103:219–229. doi: 10.1007/BF01311094. [DOI] [PubMed] [Google Scholar]
  14. Capobianchi M., Ansel H., Ameglio F., Paganelli P., Pizzoli P., Dianzani F. Recombinant glycoprotein 120 of human immunodeficiency virus is a potent interferon inducer. AIDS Res. Hum. Retroviruses. 1992;8:575–585. doi: 10.1089/aid.1992.8.575. [DOI] [PubMed] [Google Scholar]
  15. Cavalieri R.L., Havell E.A., Vilcek J., Pestka S. Vol. 74. 1977. Synthesis of human interferon by Xenopus laevis oocytes: two structural genes for interferons in human cells; pp. 3287–3291. (Proc. natn. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Cavalieri R.L., Havell E.A., Vilcek J., Pestka S. Vol. 74. 1977. Induction and decay of human fibroblast interferon mRNA; pp. 4415–4419. (Proc. natn. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Cederblad B., Alm G. Infrequent but efficient interferon-α-producing human mononuclear leukocytes by herpes simplex virus in vitro studies by immunoplaque and limiting dilution assays. Interferon Res. 1990;10:65–73. doi: 10.1089/jir.1990.10.65. [DOI] [PubMed] [Google Scholar]
  18. Cederblad B., Alm G.V. Interferons and the colony-stimulating factor-IL-3 and factor-GM-CSF enhance the IFN-alpha response in human blood leucocytes induced by herpes simplex virus. Scand. J. Immun. 1991;34:549–555. doi: 10.1111/j.1365-3083.1991.tb01578.x. [DOI] [PubMed] [Google Scholar]
  19. Cederblad B., Gobl A.E., Alm G.V. The induction of interferon-alpha and interferon-beta messenger RNA in human natural interferon-producing blood leukocytes requires de novo protein synthesis. J. Interferon Res. 1991;11:371–377. doi: 10.1089/jir.1991.11.371. [DOI] [PubMed] [Google Scholar]
  20. Charley B., Laude H. Induction of alpha interferon by transmissible gastroenteritis coronavirus: role of transmemebrane glycoprotein E1. J. Virol. 1988;62:8–11. doi: 10.1128/jvi.62.1.8-11.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Chehimi J., Starr S.E., Kawashima H., Miller D.S., Trinchieri G., Perussia B., Bandyopadhyay S. Dendritic cells and IFN-α-producing cells are two functionally distinct non-B, non-monocytic HLA-DR+ cell subsets in human peripheral blood. Immunology. 1989;68:486–490. [PMC free article] [PubMed] [Google Scholar]
  22. Colamonici O., Porterfield B., Diaz M. Interferon sensitivity of human leukemia cell lines with and without deletion of the interferon genes. J. Interferon. Res. 1991;11:S54. [Google Scholar]
  23. DeStefano E., Friedman R.M., Friedman-Kien A., Goedert J., Henrickson D., Preble O., Sonnabend J., Vilcek J. Acid labile human leukocyte interferon in homosexual men with KS and lymphadenopathy. J. Infect. Dis. 1982;146:451–459. doi: 10.1093/infdis/146.4.451. [DOI] [PubMed] [Google Scholar]
  24. Djeu J.Y., Stocks N., Zoon K., Stanton G.J., Timomen T., Herberman R.B. Positive self regulation of cytotoxicity in human natural killer cells by production of interferon upon exposure to influenza and herpes viruses. J. exp. Med. 1982;156:1222–1234. doi: 10.1084/jem.156.4.1222. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Dron M., Tovey M. Interferon α/β, gene structure and regulation. In: Baron S., Coppenhaver D., Dianzani F., Fleischmann W., Hughes T., Klimpel G., Nielsel D., Stanton G., Tyring S., editors. Interferon: Principles and Medical Applications. University of Texas Medical Branch at Galveston; Galveston, Texas: 1992. pp. 33–43. [Google Scholar]
  26. Emodi G., Just M. Impaired interferon response of children with congenital cytomegalovirus disease. Acta Pediat. Scand. 1974;63:183–187. doi: 10.1111/j.1651-2227.1974.tb04781.x. [DOI] [PubMed] [Google Scholar]
  27. Familletti P.C., McCandliss R., McCandliss R., Pestka S. Production of high levels of human leukocytes interferon from a continuous human myeloblast cell culture. Antimicrob. Agents. Chemother. 1981;20:5–9. doi: 10.1128/aac.20.1.5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Feldman M., Fritzgerald-Bocarsly P. Sequential enrichment and immunocytochemical visualization of human interferon-α producing cells. J. Interferon Res. 1990;10:435–4463. doi: 10.1089/jir.1990.10.435. [DOI] [PubMed] [Google Scholar]
  29. Feldman M., Fitzgerald-Bocarsly P. Human natural killer cells require both Ca+ and Mg2+ to lyse either HSV-1 infected fibroblasts or K562 tumor cells. FASEB J. 1992;6:A1216. [Google Scholar]
  30. Feldman M., Howell D., Fitzgerald-Bocarsly P. Interferon dependent and independent participation of accessory cells in natural killer mediated lysis of HSV-1 infection fibroblasts. J. Leukocyte Biol. 1992;52:473–482. doi: 10.1002/jlb.52.5.473. [DOI] [PubMed] [Google Scholar]
  31. Feldman S., Fitzgerald-Bocarsly P. The arginine analog canavanine inhibits IFN mRNA production in human PRBMC stimulated with simplex virus. J. Interferon Res. 1992;12(Suppl. 1):S130. [Google Scholar]
  32. Feldman S., Kloser P., Fitzgerald-Bocarsly P. AIDS patients demonstrate a progressive decline in the functional frequency of interferon-α producing cells. J. Interferon Res. 1992;12(Suppl. 1):S47. [Google Scholar]
  33. Ferbas J., Rinaldo C. Purified dendritic cells are potent procedures of IFN-α. J. Leukocyte Biol. 1992;(Suppl. 3):24. [Google Scholar]
  34. Fernandez R.C., Lee S.H.S., Fernandez L.A.V., Pope B.L., Rozee K.R. Production of interferon by peripheral blood mononuclear cells from normal individuals and patients with chronic lymphocytic leukemia. J. Interferon Res. 1986;6:573–580. doi: 10.1089/jir.1986.6.573. [DOI] [PubMed] [Google Scholar]
  35. Fitzgerald P.A., von Wussow P., Lopez C. Role of interferon in natural kill of HSV-1 infected fibroblasts. J. Immun. 1982;129:819–824. [PubMed] [Google Scholar]
  36. Fitzgerald-Bocarsly P., Schindler T.E., Siegal F.P., Lopez C. Independence of interferon production and natural killer function and association with opportunistic infection in acquired immune deficiency syndrome. In: Hoshino T., Koren H.S., Uchida A., editors. Natural Killer Activity and Its Regulation. Excerpta Medica; Amsterdam: 1984. pp. 415–419. [Google Scholar]
  37. Fitzgerald-Bocarsly P., Feldman M., Mendelsohn M., Curl S., Lopez C. Human mononuclear cells which produce interferon-alpha during NK (HSK-FS) assays are HLA-DR positive cells distinct from cytolytic natural effectors. J. Leukocyte Biol. 1988;43:323–334. doi: 10.1002/jlb.43.4.323. [DOI] [PubMed] [Google Scholar]
  38. Fitzgerald-Bocarsly P., Feldman M., Curl S., Schnell J., Denny T. Positively selected Leu-11a (CD16+) cells require the presence of accessory cells of factors for the lysis of HSV-infected fibroblasts but not HSV-infected Raji. J. Immun. 1989;143:1318–1326. [PubMed] [Google Scholar]
  39. Fitzgerald-Bocarsly P., Feldman M., Howell D.M., Kloser P. Deficient interferon-alpha production and normal NK cell activity in an AIDS patient with HIV-2 infection. J. Infect. Dis. 1989;160:1084–1085. doi: 10.1093/infdis/160.6.1084. [DOI] [PubMed] [Google Scholar]
  40. Fitzgerald-Bocarsly P., Howell D.M., Pettera L., Tehrani S., Lopez C. Immediate-early gene expression is sufficient for induction of natural killer cell-mediated lysis of herpes simplex virus type-1-infected fibroblasts. J. Virol. 1991;65:3151–3160. doi: 10.1128/jvi.65.6.3151-3160.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Gendelman H., Friedman R., Joe S., Baca L., Turpin J., Dveksler G., Meltzer M., Dieffenbach C. A selective defect of interferon-α production in human immunodeficiency virus-infected monocytes. J. exp. Med. 1990;172:1433–1442. doi: 10.1084/jem.172.5.1433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Gendelman H.E., Baca L.M., Kubrak C.A., Genis P., Burrous S., Friedman R.M., Jacobs D., Meltzer M.S. Induction of IFN-alpha in peripheral blood mononuclear cells by HIV-infected monocytes—restricted antiviral activity of the HIV-induced IFN. J. Immun. 1992;148:422–429. [PubMed] [Google Scholar]
  43. Gobl A.E., Funa K., Alm G.V. Different induction patterns of mRNA for IFN-α and -β in human mononuclear leukocytes after in vitro challenge with herpes simplex virus-infected fibroblasts and Sendai virus. J. Immun. 1988;140:3605–3609. [PubMed] [Google Scholar]
  44. Gobl A., Cederblad B., Sandberg K., Alm G. Interferon-α but not -β genes require de novo protein synthesis for efficient expression in human monocytes. Scand. J. Immun. 1992;35:177–185. doi: 10.1111/j.1365-3083.1992.tb02848.x. [DOI] [PubMed] [Google Scholar]
  45. Grandér D., Heyman M., Bröndum-Nielsen K., Liu Y., Lundgren E., Söderhäll S., Einhorn S. Interferon system in acute lymphocytic leukemia cells with or without deletions of the α/β-interferon genes. Blood. 1992;79:2076–2083. [PubMed] [Google Scholar]
  46. Green J., Yeh T., Overall J. Sequential production of IFN-alpha and immunospecific IFN-gamma by human mononuclear leukocytes exposed to herpes simplex virus. J. Immun. 1981;127:1192–1196. [PubMed] [Google Scholar]
  47. Gutterman J.U., Blumenschein G.R., Alexanian R., Yap H.-Y., Cabanillas F., Hortobagyi G.N., Hersh E.M., Rasmussen S.L., Harmon M., Kramer M., Pestka S. Leukocyte interferon-induced tumor regression in human metastatic breast cancer, multiple myeloma and malignant lymphoma. Ann. intern. Med. 1980;93:399–406. doi: 10.7326/0003-4819-93-3-399. [DOI] [PubMed] [Google Scholar]
  48. Hiscott J., Cantell K., Weissman C. Differential expression of human interferon genes. Nucl. Acids Res. 1984;12:3727–3746. doi: 10.1093/nar/12.9.3727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Ho A., Moritz T., Rensch K., Hunstein W., Kirchner H. Deficiency in interferon production of peripheral blood leukocytes from patients with non-Hodgkin lymphoma. J. Interferon Res. 1988;8:405–413. doi: 10.1089/jir.1988.8.405. [DOI] [PubMed] [Google Scholar]
  50. Howell D.M., Fitzgerald-Bocarsly P. Natural killer mediated lysis of some but not all HSV-1 or VSV infected targets requires the participation of HLA-DR positive accessory cells. Immunology. 1991;72:443–447. [PMC free article] [PubMed] [Google Scholar]
  51. Howell D., Feldman M., Siegal F., Pettera L., Fitzgerald-Bocarsly P. Peripheral blood of AIDS patients contains cells capable of providing accessory function for the natural killer cell mediated lysis of herpes simplex virus infected targets despite low interferon-α production. J. AIDS. 1993;6:15–23. [PubMed] [Google Scholar]
  52. Inaba K., Steinman R.M. Monoclonal antibodies to LFA-1 and to CD4 inhibit the mixed leukocyte reaction after the antigen-dependent clustering the dendritic cells and T lymphocytes. J. exp. Med. 1987;165:1403–1417. doi: 10.1084/jem.165.5.1403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Isaacs A., Lindenmann J. Vol. 147. 1957. Virus interference. 1. The interferon; p. 258. (Proc. R. Soc. Biol.). [Google Scholar]
  54. Ito Y., Nishiyama Y., Shimokata K., Takeyama H., Kunii A. Active component of HVJ (Sendai virus) for interferon induction in mice. Nature. 1978;274:801–802. doi: 10.1038/274801a0. [DOI] [PubMed] [Google Scholar]
  55. Jonsson L., Alm G., Thomander L. Elevated serum interferon levels in patients with Bell's palsy. Arch. Otalaryngol. Head Neck Surg. 1989;115:37–40. doi: 10.1001/archotol.1989.01860250039022. [DOI] [PubMed] [Google Scholar]
  56. Kato T., Minagawa T. Cellular source of interferon induced in human peripheral blood mononuclear leukocytes by mumps virus or tumor cells persistently infected with mumps virus. J. Gen. Virol. 1981;54:293–299. doi: 10.1099/0022-1317-54-2-293. [DOI] [PubMed] [Google Scholar]
  57. Kikuta H., Nakane A., Lu H., Taguchi Y., Minagawa T., Matsumoto S. Interferon induction by human herpesvirus 6 human mononuclear cells. J. Infect. Dis. 1990;162:35–38. doi: 10.1093/infdis/162.1.35. [DOI] [PubMed] [Google Scholar]
  58. Kingsbury D.W. Paramyxoviridae and their replication j. In: Fields B., Knipe D., editors. Fields Virology. Raven Press; New York: 1990. pp. 945–962. [Google Scholar]
  59. Knight S.C., Farrant J., Bryant A., Edwards A.J., Burman S., Lever A., Clarke J., Webster A.D.B. Non-adherent, low-density cells from human peripheral blood dendritic cells and monocytes, both with veiled morphology. Immunology. 1986;57:595–603. [PMC free article] [PubMed] [Google Scholar]
  60. Kontsek P., Borecky L., Kontsekova E., Novak M., Krchnak V. Antigenic link between human interferon-alpha and interferon-beta—the common epitope-1. J. Interferon. Res. 1990;10:119–128. doi: 10.1089/jir.1990.10.119. [DOI] [PubMed] [Google Scholar]
  61. Kurane I., Ennis F.A. Induction of interferon-α from human lymphocytes by autologous, Dengue virus-infected monocytes. J. exp. Med. 1987;166:999–1010. doi: 10.1084/jem.166.4.999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Kurzrock R., Talpaz M., Gutterman J. Hairy cell leukemia: review of treatment. Br. j. Hemeat. 1991;79(Suppl. 1):17–20. doi: 10.1111/j.1365-2141.1991.tb08112.x. [DOI] [PubMed] [Google Scholar]
  63. Langer J., Pestka S. Interferon receptors. Immun. Today. 1988;9:393–400. doi: 10.1016/0167-5699(88)91241-8. [DOI] [PubMed] [Google Scholar]
  64. Laude H., Gelfi J., Lavenant L., Charley B. Single amino acid changes in the viral glycoprotein M affect induction of alpha interferon by the coronavirus transmissible gastroenteritis virus. J. Virol. 1992;66:743–749. doi: 10.1128/jvi.66.2.743-749.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Lebon P. Inhibition of herpes simplex virus type-1 induced interferon synthesis by monoclonal antibodies viral glycoprotein D by lysosomotropic drugs. J. gen. Virol. 1985;66:2781–2786. doi: 10.1099/0022-1317-66-12-2781. [DOI] [PubMed] [Google Scholar]
  66. Lebon P., Bernard A., Boumsell L. Identificaition de populations lymphocytaires productrices d'interferon par les anticorps monoclonaux. C.R. Acad. Sci. Paris Ser. 1982;295:79–82. 3. [PubMed] [Google Scholar]
  67. Lee S., Fernandez L., Rozee K. Further observation on interferon producton by chronic lymphocytic leukemia cells. Eur. J. Cancer clin. Oncol. 1984;20:719–720. doi: 10.1016/0277-5379(84)90022-1. [DOI] [PubMed] [Google Scholar]
  68. Levin S., Hahn T. Interferon system in acute viral hepatitis. Lancet. 1982;i:592–594. doi: 10.1016/s0140-6736(82)91751-2. [DOI] [PubMed] [Google Scholar]
  69. Ligal M., Johnson D. A herpes simplex virus mutant in which glycoprotein sequences are replaced by β-galactosidase sequences binds to but is unable to penetrate into cells. J. Virol. 198;62:1486–1494. doi: 10.1128/jvi.62.5.1486-1494.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Lindenmann J. Induction to chick interferon: procedures of the original experiments. Meth. Enzym. 1981;78:181–188. doi: 10.1016/0076-6879(81)78115-1. [DOI] [PubMed] [Google Scholar]
  71. Lopez C., Fitzgerald P.A., Siegal F.P. Severe acquired immune deficiency syndrome in male homosexuals: diminished capacity to make interferon-α in vitro associated with severe opportunistic infections. J. Infect. Dis. 1983;148:962–966. doi: 10.1093/infdis/148.6.962. [DOI] [PubMed] [Google Scholar]
  72. Lopez C., Fitzgerald P., Siegal F. Human interferon-alpha production in homosexual men with the acquired immune deficiency syndrome. J. Infect. Dis. 1984;150:158. doi: 10.1093/infdis/150.1.158. [DOI] [PubMed] [Google Scholar]
  73. Macatonia S.E., Lau R., Patterson S., Pinching A.J., Knight S.C. Dendritic cell infection, depletion and dysfunction in HIV-infected individuals. Immunology. 1990;71:38–45. [PMC free article] [PubMed] [Google Scholar]
  74. Meager A., Berg K. Epitope localization of a monoclonal antibody, LO-22, with broad specificity for interferon-α subtypes. J. Interferon Res. 1986;6:729–736. doi: 10.1089/jir.1986.6.729. [DOI] [PubMed] [Google Scholar]
  75. Merlin G., Falcoff E., Aguet M. 125I-labelled human interferon alpha, beta and gamma: comparative receptor-binding data. J. gen. Virol. 1985;66:1149–1152. doi: 10.1099/0022-1317-66-5-1149. [DOI] [PubMed] [Google Scholar]
  76. Merrill J.E., Ellison G.W., Myers L.W. Cytotoxic activity of peripheral blood and cerebrospinal fluid lymphocytes from patients with multiple sclerosis and other neurological diseases: analysis at the single cell level of the relationship of cytotoxic effectors and interferon-producing cells. Clin. Immun. Immunopath. 1984;31:390–402. doi: 10.1016/0090-1229(84)90091-6. [DOI] [PubMed] [Google Scholar]
  77. Minagawa T., Mizuno K., Hirano S., Asano M., Numata A., Kohanawa M., Negishi M., Yamazaki S., Satoh Y. Detection of high levels of immunoreactive human beta-1 interferon in sera from HIV-infected patients. Life Sci. 1989;45:3–7. doi: 10.1016/0024-3205(89)90147-1. [DOI] [PubMed] [Google Scholar]
  78. Neighbor P.A., Miller A., Bloom B. Interferon responses of leukocytes in multiple sclerosis. Neurology. 1981;31:561–566. doi: 10.1212/wnl.31.5.561. [DOI] [PubMed] [Google Scholar]
  79. Oh S.H., Bandyopadhyay S., Miller D.S., Starr S.E. Cooperation between CD16(Leu-11b)+ NK cells and HLA-DR+ cells in natural killing of herpes virus-infected fibroblasts. J. Immun. 1987;139:2799–2802. [PubMed] [Google Scholar]
  80. Okabe M., Minagawa T., Nakane A., Sakurada K., Miyazaki T. Impaired alpha-interferon production and natural killer activity in blood mononuclear cells in myelodysplastic syndromes. Scand. J. Hemeat. 1986;37:111–117. doi: 10.1111/j.1600-0609.1986.tb01783.x. [DOI] [PubMed] [Google Scholar]
  81. Perez N., Lasarte P., Bibiloni N., Dejean C. Alpha/beta interferon in serum from children with the hemolytic uremic syndrome. Acta Paediatr. Scand. 1989;78:637–638. doi: 10.1111/j.1651-2227.1989.tb17953.x. [DOI] [PubMed] [Google Scholar]
  82. Perussia B., Fanning V., Trinchieri G. A leukocyte subset bearing HLA-DR antigens is responsible for in vitro alpha interferon production in response to viruses. Nat. Immun. Cell Growth Regul. 1985;4:120–137. [PubMed] [Google Scholar]
  83. Pestka S. Interferon from 1981 to 1986. Meth. Enzym. 1986;119:3–14. doi: 10.1016/0076-6879(86)19003-3. [DOI] [PubMed] [Google Scholar]
  84. Pestka S., Langer J.A, Zoon K.C., Samuel C.E. Interferons and their actions. A. Rev. Biochem. 1987;56:727–777. doi: 10.1146/annurev.bi.56.070187.003455. [DOI] [PubMed] [Google Scholar]
  85. Peter H.H., Dalluge H., Zawatzky R., Euler S., Leibold W., Kirchner H. Human peripheral null lymphocytes II. Production of type-1 interferon upon stimulation with tumor cells, herpes simplex virus and Corynebacterium parvum. Eur. J. Immun. 1980;10:547–555. doi: 10.1002/eji.1830100712. [DOI] [PubMed] [Google Scholar]
  86. Preble O., Black R., Friedman R., Klippel J., Vilcek J. Systematic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte α-interferon. Science. 1982;216:429–431. doi: 10.1126/science.6176024. [DOI] [PubMed] [Google Scholar]
  87. Rasanan L., Lehto M., Leinikki P. Enrichment of dendritic cells from human peripheral blood. J. Leukocyte Biol. 1988;43:343–348. doi: 10.1002/jlb.43.4.343. [DOI] [PubMed] [Google Scholar]
  88. Rassiga-Pidot A., McIntyre O. In vitro leukocyte interferon production in patients with Hodgkin's disease. Cancer Res. 1984;34:2995–3002. [PubMed] [Google Scholar]
  89. Rhodes-Feuillette A., Canivet M., Campsaur H., Gluckman E., Mazeron M., Peries J. Circlating interferon in cytomegalovirus infected bone-marrow-tranplant recipients and in infants with congenital cytomegalovirus disease. J. Interferon Res. 1983;3:45–52. doi: 10.1089/jir.1983.3.45. [DOI] [PubMed] [Google Scholar]
  90. Rönnblom L., Alm G.V. Limiting dilution analysis of human peripheral blood mononuclear leukocytes that react to human amnion cells and protect these against viral challenge. Eur. J. Immun. 1982;12:437–441. doi: 10.1002/eji.1830120515. [DOI] [PubMed] [Google Scholar]
  91. Rönnblum L., Forsgren A., Alm G.V. Characterization of interferons induced by bacteria and interferon-producing leukocytes in human blood. Infect. Immun. 1983;40:126–132. doi: 10.1128/iai.40.1.126-132.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Rönnblom L., Ramstedt U., Alm G.V. Properties of human natural interferon-producing cells stimulated by tumor cell lines. Eur. J. Immun. 1983;13:471–476. doi: 10.1002/eji.1830130608. [DOI] [PubMed] [Google Scholar]
  93. Rönnblom L., Cederblad B., Sandberg K., Alm G.V. Determination of herpes simplex virus-induced alpha interferon-secreting human blood leucocytes by a filter immuno-plasque assay. Scand. J. Immun. 1988;27:165–170. doi: 10.1111/j.1365-3083.1988.tb02335.x. [DOI] [PubMed] [Google Scholar]
  94. Rossol S., Voth R., Laubenstein H.P., Müller W.E.G., Schröder H.C., Meyer zum Büchsenfelde K.H., Hess G. Interferon production in patients infected with HIV-1. J. Infect. Dis. 1989;159:815–821. doi: 10.1093/infdis/159.5.815. [DOI] [PubMed] [Google Scholar]
  95. Rosztóczy I., Papós M. The role of the various human peripheral blood mononuclear cells in the production of Sendai virus-induced interferon: IFN mRNA studies. J. Interferon. Res. 1989;9:349–352. doi: 10.1089/jir.1989.9.349. [DOI] [PubMed] [Google Scholar]
  96. Rubinstein M., Rubinstein S., Familletti P.C., Gross M.S., Miller R.S., Waldman A.A., Pestka S. Human leukocyte interferon purified to homogeneity. Science. 1978;202:1289–1290. doi: 10.1126/science.725605. [DOI] [PubMed] [Google Scholar]
  97. Rubinstein M., Rubinstein S., Familletti P.C., Miller R.S., Waldman A.A., Pestka S. Vol. 76. 1979. Human leukocyte interferon: production, purification to homogeneity and initial characterization; pp. 640–644. (Proc. natn. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Rubinstein M., Levin W.P., Moschera J.A., Lai C.-Y., Hershberg R.D., Bartlett R.T., Pestka S. Human leukocyte interferon: isolation and characterization of several molecular forms. Arch. Biochem. Biophys. 1981;210:307–318. doi: 10.1016/0003-9861(81)90194-6. [DOI] [PubMed] [Google Scholar]
  99. Saksela E., Virtanen I., Hovi T., Secher D.S., Cantell K. Monocyte is the main producer of human leukocyte alpha interferons following Sendai virus induction. Prog. med. Virol. 1984;30:78–86. [PubMed] [Google Scholar]
  100. Sandberg K., Gobl A.E., Funa K., Alm G. Characterization of the blood mononuclear leukocytes producing alpha interferon after stimulation with herpes simplex virus in vitro, by means of combined immunohistochemical staining and in situ RNA-RNA hybridization. Scand. J. Immun. 1989;29:651–658. doi: 10.1111/j.1365-3083.1989.tb01169.x. [DOI] [PubMed] [Google Scholar]
  101. Sandberg K., Matsson P., Alm G.V. A distinct population of nonphagocytic and low level CD4+ null lymphocytes produce IFN-alpha after stimulation by herpes simplex virus-infected cells. J. Immun. 1990;145:1015–1020. [PubMed] [Google Scholar]
  102. Sandberg K., Eloranta M.L., Gobl A.E., Alm G.V. Phorbol ester-mediated inhibition of IFN-alpha/beta gene transcription in blood mononuclear leukocytes. J. Immun. 1991;147:3116–3121. [PubMed] [Google Scholar]
  103. Sandberg K., Eloranta M.L., Johannisson A., Alm G.V. Flow cytometric analysis of natural interferon-alpha producing cells. Scand. J. Immun. 1991;34:565–576. doi: 10.1111/j.1365-3083.1991.tb01580.x. [DOI] [PubMed] [Google Scholar]
  104. Shows T.B., Sakaguchi A.Y., Naylor S.L., Goeddel D.V., Lawn R.M. Clustering of leukocyte and fibroblast interferon genes on human chromosome 9. Science. 1982;218:373–374. doi: 10.1126/science.6181564. [DOI] [PubMed] [Google Scholar]
  105. Siegal F.P., Lopez C., Fitzgerald P.A., Shah K., Baron P., Leiderman I.Z., Imperato D., Landesman S. Opportunistic infections in acquired immune deficiency syndrome result from synergestic defects of both natural and adaptive components of cellular immunity. J. clin. Invest. 1986;78:115–123. doi: 10.1172/JCI112539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  106. Stanwick T.L., Campbell D.E., Nahmias A.J. Cytotoxic properties of human monocyte-macrophages for human fibroblasts infected with herpes simplex virus: interferon production and augmentation. Cell. Immun. 1982;70:132–147. doi: 10.1016/0008-8749(82)90139-3. [DOI] [PubMed] [Google Scholar]
  107. Stewart W.E. Interferon nomenclature. Nature. 1980;286:110. doi: 10.1038/286110a0. [DOI] [PubMed] [Google Scholar]
  108. Stewart W.E. Second edn. Springer-Verlag; New York: 1981. The Interferon System. [Google Scholar]
  109. Timonen T., Saksela E., Virtanen I., Cantell K. Natural killer cells are responsible for the inteferon production induced in human lymphocytes by tumore cell contact. Eur. J. Immun. 1980;10:422–427. [Google Scholar]
  110. Tolentino P., Dianzani F., Zucca M., Giacchio R. Decreased interferon response by lymphocytes from children with chronic hepatitis. J. Infect. Dis. 1975;32:459–461. doi: 10.1093/infdis/132.4.459. [DOI] [PubMed] [Google Scholar]
  111. Torrence P.F., De Clercq E. Interferon inducers: general survey and classification. Meth. Enzym. 1981;79:291–299. doi: 10.1016/0076-6879(81)78130-8. [DOI] [PubMed] [Google Scholar]
  112. Tovey M.G., Streuli M., Gresser I., Gugenheim J., Blanchard B., Guymarho J., Vignaux F., Gigou M. Vol. 84. 1987. Interferon messenger RNA is produced constitutively in the organs individuals; pp. 5038–5042. (Proc. natn. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  113. Tovey M., Lebon P., Meyer F., Hurtrel B., Gresser I., Venet A., Girard M. The role of interferon in the development of AIDS. J. Interferon. Res. 1992;12(Suppl. 1):S62. [Google Scholar]
  114. Trinchieri G., Santoli D., Dee R.R., Knowles B.B. Anti-viral activity induced by culturing lymphocytes with tumor derived or virus-transformed cells. Identification of the anti-viral activity as interferon and characterization of the human effector lymphocyte subpopulation. J. exp. Med. 1978;147:1299–1313. doi: 10.1084/jem.147.5.1299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  115. Trinchieri G., Santoli D., Koprowski H. Spontaneous cell-mediated cytotoxicity in humans: role of interferon and immunoglobulins. J. Immun. 1978;120:1849–1855. [PubMed] [Google Scholar]
  116. Uze G., Lutfalla G., Gresser I. Genetic transfer of a functional human interferon-α receptor into mouse cells: cloning and expression of its cDNA. Cell. 1990;60:225–234. doi: 10.1016/0092-8674(90)90738-z. [DOI] [PubMed] [Google Scholar]
  117. Voth R., Rossol S., Klein K., Hess G., Schutt K.H., Schroder H.C., Zumbuschenfelde K.H.M., Muller W.E.G. Differential gene expression of IFN-alpha and tumor necrosis factor-alpha in peripheral blood mononuclear cells from patients with AIDS related complex and AIDS. J. Immun. 1990;144:970–975. [PubMed] [Google Scholar]
  118. Weigent D.A., Langford M.P., Smith E.M., Blalock J.E., Stanton G.J. Human B lymphocytes produce leukocyte interferon after interaction with foreign cells. Infect. Immun. 1981;32:508–512. doi: 10.1128/iai.32.2.508-512.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  119. Weissmann C., Weber H. The interferon genes. Prog. Nucl. Acid Res. Molec. Biol. 1986;33:251–300. doi: 10.1016/s0079-6603(08)60026-4. [DOI] [PubMed] [Google Scholar]
  120. Wiranowska-Stewart M., Stewart W. Determinatin of human leukocyte populations involved in production of interferons alpha and gamma. J. Inteferon Res. 1981;1:233–244. doi: 10.1089/jir.1981.1.233. [DOI] [PubMed] [Google Scholar]
  121. Yasuda Y., Ohgitani E., Yamada A., Hosaka Y., Uno K., Imanishi J., Kishida T. Induction of interferon-α in human peripheral blood mononuclear cells by influenza virus: role of viral glycoproteins. J. Interferon Res. 1992;12(Suppl. 1):s141. [Google Scholar]
  122. Yee A.M.F., Buyon J.P., Yip Y.K. Interferon alpha associated with systemic lupus erythematosus is not intrinsically acid labile. J. exp. Med. 1989;169:987–993. doi: 10.1084/jem.169.3.987. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Pharmacology & Therapeutics are provided here courtesy of Elsevier

RESOURCES